title: In reply.
authors.forename: Alyx C
authors.initials: AC
authors.lastname: Rosen
authors.forename: Igor T
authors.initials: IT
authors.lastname: Gavrilovic
authors.forename: Yevgeniy
authors.initials: Y
authors.lastname: Balagula
authors.forename: Vijay
authors.initials: V
authors.lastname: Ramaswamy
authors.forename: Maura N
authors.initials: MN
authors.lastname: Dickler
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Dunkel
authors.forename: Mario E
authors.initials: ME
authors.lastname: Lacouture
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009061:Mouth Mucosa / Q000187:drug effects*; D014059:Tongue / Q000187:drug effects*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized